JUL 20, 2021 7:00 AM PDT

Coronavirus Variants No Match Against Newly-Discovered Antibody

WRITTEN BY: Tara Fernandez

Over 940 million people around the world have been fully vaccinated. But, as the World Health Organization warns, the global pandemic is far from over. The emergence of SARS-CoV-2 variants that are more contagious and cause more severe, potentially fatal infections point to a genuine threat that dangerous new mutants could start to take over and undermine existing pandemic countermeasures. 

A recent study could provide a light at the end of the tunnel. A team of immunologists led by Tyler Starr at the Fred Hutchinson Cancer Research Center in Seattle has identified a potent antibody capable of neutralizing SARS-CoV-2 and its variants. In addition, the antibody can also protect against a range of coronaviruses closely related to SARS-CoV-2, opening up the possibility of creating "variant-proof" COVID treatments and vaccines in the future.

SARS-CoV-2 acquires mutations that allow it to evade the immune system, escaping detection by antibodies. To solve this problem, the scientists began searching for antibodies that retained their effectiveness against SARS-CoV-2, even those in disguise.

Starr's team analyzed a panel of 12 antibodies that were isolated from patients who had previously recovered from COVID-19 or similar coronavirus infections. They then tested this library of antibodies against a panel of thousands of known mutations that typically arise in a region of the virus called the receptor binding domain.

They found that one antibody, called S2H97, stood head and shoulders above the others in terms of its ability to attach to binding domains in multiple coronaviruses. It also helped shield against infection by a suite of SARS-CoV-2 variants in both cell-based laboratory assays and experiments in hamsters.

With follow-on preclinical testing, S2H97 may prove to be an indispensable weapon in our ongoing battle against SARS-CoV-2. "These data highlight principles underlying variation in escape, breadth, and potency among antibodies targeting the RBD, and identify epitopes and features to prioritize for therapeutic development against the current and potential future pandemics," wrote the authors.

 

Source: Nature.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
MAR 31, 2021
Microbiology
Deep-Sea Microbes Are 'Invisible' to the Human Immune System
MAR 31, 2021
Deep-Sea Microbes Are 'Invisible' to the Human Immune System
Scientists took an exploratory journey to a place in the central Pacific Ocean in Kirbati called the Phoenix Islands Pro ...
APR 06, 2021
Cell & Molecular Biology
New Insight Into a Crucial Immune Cell
APR 06, 2021
New Insight Into a Crucial Immune Cell
Dendritic cells are a crucial part of the immune response; they look out for the presence of pathogenic invaders like vi ...
APR 15, 2021
Immunology
COVID Vaccines Protect Breastfeeding Babies Too
APR 15, 2021
COVID Vaccines Protect Breastfeeding Babies Too
Good news for families of newborns: A new study shows that breastfeeding mothers who receive a COVID vaccine share prote ...
APR 28, 2021
Cell & Molecular Biology
Learning More About the Sugars That Mediate Immune Interactions
APR 28, 2021
Learning More About the Sugars That Mediate Immune Interactions
Sugar is something sweet to add to your food, but just like fat, different types of sugars play important roles in biolo ...
MAY 13, 2021
Immunology
Tumors Hide From the Immune System by Masquerading as Baby Cells
MAY 13, 2021
Tumors Hide From the Immune System by Masquerading as Baby Cells
The immune system is programmed to recognize foreign bodies as potentially dangerous, promptly removing them before the ...
JUL 12, 2021
Cell & Molecular Biology
A Molecule From the Gut Microbiome May Fight Tumors
JUL 12, 2021
A Molecule From the Gut Microbiome May Fight Tumors
The more we learn abut the gut microbiome, the more it seems that the microorganisms in our gastrointestinal tracts can ...
Loading Comments...